Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients

Dig Dis Sci. 2016 Nov;61(11):3278-3284. doi: 10.1007/s10620-016-4189-z. Epub 2016 May 20.

Abstract

Aim: To investigate whether a diagnostic delay is associated with a poor outcome in Crohn's disease (CD).

Methods: Medical and socioeconomic characteristics as well as medications and need for surgery of consecutive CD adults patients followed in three referral centers were prospectively recorded using an electronic database (Focus_MICI®). A long diagnostic delay was defined by the upper quartile. We compared patients with long diagnostic delay to those with earlier diagnosis regarding the time to: (1) first intestinal surgery, (2) first use of immunosuppressants (IMSs), and (3) first use of anti-tumor necrosis factor (anti-TNF) therapy using the Kaplan-Meier test and the log-rank test.

Results: A total of 497 patients with CD (53.6 % women) were analyzed. Median diagnostic delay was 5 months (IQR 25-75 %: 2-13 months). Median follow-up was 9 years (IQR 4-16.2), and 148 (29.8 %) patients had major surgery. There were no significant differences between patients with late and early diagnosis regarding age at diagnosis, disease phenotype, need for IMS therapy, and need for anti-TNF therapy. Time to first major surgery was shorter in patients with late diagnosis (p = 0.05).

Conclusion: In this large multicenter prospective cohort of French CD patients, a long diagnostic delay (>13 months) increased the risk of early surgery. No associated factors could be identified in this study.

Keywords: Crohn’s disease; Diagnostic delay; Surgery.

MeSH terms

  • Adalimumab / therapeutic use
  • Adult
  • Cohort Studies
  • Colectomy / statistics & numerical data
  • Constriction, Pathologic / etiology
  • Constriction, Pathologic / surgery
  • Crohn Disease / complications
  • Crohn Disease / diagnosis*
  • Crohn Disease / therapy
  • Delayed Diagnosis / statistics & numerical data*
  • Digestive System Surgical Procedures / statistics & numerical data*
  • Enterostomy / statistics & numerical data
  • Female
  • France
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab / therapeutic use
  • Intestinal Obstruction / etiology
  • Intestinal Obstruction / surgery
  • Jejunum / surgery
  • Kaplan-Meier Estimate
  • Male
  • Methotrexate / therapeutic use
  • Prospective Studies
  • Risk
  • Time Factors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Methotrexate